For Some African-Americans, Genetic Testing Reopens Past Wounds
By Amy Dockser Marcus,
The Wall Street Journal
| 07. 14. 2018
Late last year, Justina Crawford decided to swab the inside of her mouth for a saliva sample to do a DNA test.
Ms. Crawford, a 30-year-old working in Boston who is African-American, had never done a DNA test before because she worried about who would have access to her genetic information. But her growing curiosity about her family history led her to set her reservations aside. “I want to know my roots,” she said, and purchased a kit from African Ancestry Inc., a DNA testing company.
Scientists and private genetic testing companies are making a push to enroll more African-Americans in genetic research and databases. As the popularity and wider availability of genetic testing grows, so have calls from the scientific community about the need for genetic diversity in future research. In the past, genomic research was predominantly skewed to people of European ancestry. As a result, African-Americans—as well as people of different demographic backgrounds—weren’t well represented in some important health research.
But before they sign up, many African-Americans have to overcome concern about potential misuse of DNA results and...
see more
Related Articles
By Darrell Etherington, TechCrunch | 12.29.2020
By Francis S. Collins, M.D., Ph.D., Jennifer A. Doudna, Ph.D., Eric S. Lander, Ph.D., and Charles N. Rotimi, Ph.D., The New England Journal of Medicine | 01.07.2021
The breathtaking progress in molecular genetics that has occurred over the past five decades and the transition to genomic medicine would have been difficult to imagine in 1970, when the Institute of Medicine (IOM), now the National Academy of Medicine...
By Megan Molteni , Wired | 12.30.2020
IN 1987, WHEN researchers first used the word genomics to describe the newly developing discipline of mapping DNA, Eric Green had just finished medical school. A few years later, he found himself working on the front lines of the young field’s...
By Jocelyn Kaiser, Science | 12.22.2020
It’s troubling news that gene therapy researchers have long anticipated: A hemophilia patient injected with a virus carrying a therapeutic gene in a clinical trial has developed a liver tumor. The U.S. Food and Drug Administration (FDA) has halted the...
